Table 4.
Predictor (univariate analysis) | Hazard ratio | 95% Confidence Interval (95%CI) | p value |
---|---|---|---|
Age > 60 years | 1.0 | 0.7 - 1.5 | 0.998 |
Male gender | 0.8 | 0.5 - 1.2 | 0.247 |
Etiology: | |||
Ischemic | 0.8 | 0.5 - 1.3 | 0.389 |
Non-ischemic (non-chagasic) | 0.7 | 0.5 - 1.1 | 0.124 |
Chagasic | 1.8 | 1.2 - 2.7 | 0.008 |
LVEF < 0.25 | 0.8 | 0.6 - 1.3 | 0.382 |
Anemia | 1.0 | 0.7 - 1.6 | 0.939 |
Urea ≥ 60 mg/dL | 1.7 | 1.1 - 2.5 | 0.013 |
Creatinine ≥ 1.4 mg/dL | 1.6 | 1.1 - 2.4 | 0.013 |
Sodium ≤ 135 mEq/L | 1.8 | 1.2 - 2.6 | 0.004 |
SBP < 90 mmHg | 0.9 | 0.5 - 1.5 | 0.640 |
Medications | |||
Inotropic agents | 1.7 | 1.1 - 2.7 | 0.008 |
ACEI | 0.6 | 0.4 - 0.9 | 0.020 |
Beta-blocker | 0.3 | 0.2 - 0.5 | <0.001 |
Losartan | 1.1 | 0.6 - 2.0 | 0.788 |
Nitrates | 1.6 | 1.1 - 2.4 | 0.017 |
Hydralazine | 1.4 | 0.9 - 2.1 | 0.097 |
Digoxin | 1.4 | 0.9 - 2.2 | 0.106 |
Spironolactone | 0.7 | 0.4 - 1.3 | 0.274 |
Hydrochlorothiazide | 1.2 | 0.7 - 2.0 | 0.483 |
Furosemide | 1.4 | 0.8 - 2.4 | 0.205 |
Predictor (multivariate analysis) | Hazard ratio | 95% confidence Interval | p value |
Creatinine ≥ 1,4 mg/dL | 2.0 | 1.3 - 3.0 | 0.002 |
Chagasic etiology | 1.9 | 1.3 - 3.0 | 0.002 |
ACEI | 0.6 | 0.4 - 0.9 | 0.040 |
Beta-blocker | 0.3 | 0.2 - 0.5 | < 0.001 |
Sodium ≤ 135 mEq/L | 1.8 | 1.2 - 2.7 | 0.003 |
LVEF: left ventricular ejection fraction; SBP: systolic blood pressure; ACEI: angiotensin-converting enzyme inhibitor.